complaining that Amgen's stock price has languished as other companies of a similar size have done much, much better this year. Amgen reported today that it spent $979 million on R&D in the second quarter, a 4% jump over what it spent in the same …
Fierce Biotech · ByJohn Carroll · 7/29/2014
U.S. stocks rose, after the biggest gain in more than a month for the Standard & Poor’s 500 Index, amid optimism over corporate earnings. Comcast Corp. advanced after increasing its stock buyback. Berkshire Hathaway Inc. climbed 1.7 percent as lower …
MSN · 4/5/2015
More from Bing News